These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30457455)

  • 1. Design of novel multi-epitope vaccines against severe acute respiratory syndrome validated through multistage molecular interaction and dynamics.
    Srivastava S; Kamthania M; Kumar Pandey R; Kumar Saxena A; Saxena V; Kumar Singh S; Kumar Sharma R; Sharma N
    J Biomol Struct Dyn; 2019 Oct; 37(16):4345-4360. PubMed ID: 30457455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and Validation.
    Srivastava S; Verma S; Kamthania M; Kaur R; Badyal RK; Saxena AK; Shin HJ; Kolbe M; Pandey KC
    JMIR Bioinform Biotechnol; 2020; 1(1):e19371. PubMed ID: 32776022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the structural basis to develop efficient multi-epitope vaccines displaying interaction with HLA and TAP and TLR3 molecules to prevent NIPAH infection, a global threat to human health.
    Srivastava S; Verma S; Kamthania M; Saxena AK; Pandey KC; Pande V; Kolbe M
    PLoS One; 2023; 18(3):e0282580. PubMed ID: 36920996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach.
    Srivastava S; Kamthania M; Singh S; Saxena AK; Sharma N
    Infect Drug Resist; 2018; 11():2377-2391. PubMed ID: 30538505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
    Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
    Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins.
    Tsao YP; Lin JY; Jan JT; Leng CH; Chu CC; Yang YC; Chen SL
    Biochem Biophys Res Commun; 2006 May; 344(1):63-71. PubMed ID: 16630549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach.
    Naz A; Shahid F; Butt TT; Awan FM; Ali A; Malik A
    Front Immunol; 2020; 11():1663. PubMed ID: 32754160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes.
    Liu J; Sun Y; Qi J; Chu F; Wu H; Gao F; Li T; Yan J; Gao GF
    J Infect Dis; 2010 Oct; 202(8):1171-80. PubMed ID: 20831383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch vaccines, designed by reverse epitomics approach, show potential to cover large ethnically distributed human population worldwide.
    Srivastava S; Verma S; Kamthania M; Agarwal D; Saxena AK; Kolbe M; Singh S; Kotnis A; Rathi B; Nayar SA; Shin HJ; Vashisht K; Pandey KC
    J Biomol Struct Dyn; 2022 Mar; 40(5):2369-2388. PubMed ID: 33155524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches.
    Dong R; Chu Z; Yu F; Zha Y
    Front Immunol; 2020; 11():1784. PubMed ID: 32849643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach.
    Bhattacharya M; Sharma AR; Patra P; Ghosh P; Sharma G; Patra BC; Lee SS; Chakraborty C
    J Med Virol; 2020 Jun; 92(6):618-631. PubMed ID: 32108359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses.
    Huang J; Cao Y; Du J; Bu X; Ma R; Wu C
    Vaccine; 2007 Sep; 25(39-40):6981-91. PubMed ID: 17709158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
    Jakhar R; Kaushik S; Gakhar SK
    J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A candidate multi-epitope vaccine against SARS-CoV-2.
    Kar T; Narsaria U; Basak S; Deb D; Castiglione F; Mueller DM; Srivastava AP
    Sci Rep; 2020 Jul; 10(1):10895. PubMed ID: 32616763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope-based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study.
    Tahir Ul Qamar M; Saleem S; Ashfaq UA; Bari A; Anwar F; Alqahtani S
    J Transl Med; 2019 Nov; 17(1):362. PubMed ID: 31703698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein.
    Liu J; Wu P; Gao F; Qi J; Kawana-Tachikawa A; Xie J; Vavricka CJ; Iwamoto A; Li T; Gao GF
    J Virol; 2010 Nov; 84(22):11849-57. PubMed ID: 20844028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HHV-5 epitope: A potential vaccine candidate with high antigenicity and large coverage.
    Kumar N; Singh A; Grover S; Kumari A; Kumar Dhar P; Chandra R; Grover A
    J Biomol Struct Dyn; 2019 May; 37(8):2098-2109. PubMed ID: 30044169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
    Yang Z; Bogdan P; Nazarian S
    Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach.
    Mahmud S; Rafi MO; Paul GK; Promi MM; Shimu MSS; Biswas S; Emran TB; Dhama K; Alyami SA; Moni MA; Saleh MA
    Sci Rep; 2021 Jul; 11(1):15431. PubMed ID: 34326355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection.
    Mahapatra SR; Sahoo S; Dehury B; Raina V; Patro S; Misra N; Suar M
    Expert Rev Vaccines; 2020 Sep; 19(9):871-885. PubMed ID: 32869699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.